0 items

in your cart
$0.00

Drug Search > Tazarotene

Prescription Drug Search

Strengths available for Tazarotene cream:

Tazarotene cream 0.05%
Tazarotene cream 0.1%

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Tazarotene:

  • Antigua and Barbuda
  • Argentina
  • Aruba
  • Azerbaijan
  • Bahrain
  • Bangladesh
  • Bermuda
  • Bolivia
  • Bosnia and Herzegovina
  • Brazil
  • Egypt
  • European Union
  • France
  • Guam
  • Guatemala
  • Hungary
  • India
  • Indonesia
  • Iran
  • Ireland
  • Italy
  • Jamaica
  • Kuwait
  • Lebanon
  • Mauritius
  • Morocco
  • Netherlands Antilles
  • Philippines
  • Qatar
  • Saint Lucia
  • Saudi Arabia
  • Slovakia
  • South Africa
  • Sri Lanka
  • Tonga
  • Trinidad and Tobago
  • Ukraine
  • United Kingdom, UK
  • United States, US
  • Uzbekistan
View All Countries

Latest news releases on Tazarotene:

Glaxo's Acne Drug Gets U.S. Nod - Analyst Blog - NASDAQ

GlaxoSmithKline ( GSK) recently announced that its subsidiary Stiefel's Fabior (tazarotene) Foam, 0.1%, received approval from the U.S. Food and Drug Administration (FDA). Fabior Foam, 0.1% is approved as a topical treatment for acne vulgaris in ...

US FDA approves Stiefel's Fabior Foam, 0.1% to treat acne - pharmabiz.com

The US Food and Drug Administration has approved Stiefel's, a GSK company, New Drug Application for Fabior (tazarotene) Foam, 0.1 per cent. It is the only retinoid in a topical foam formulation for the treatment of acne vulgaris in patients 12 years of age ...

Stiefel receives US FDA approval of Fabior Foam, 0.1% - Phramalive.com

RESEARCH TRIANGLE PARK, N.C., May 11, 2012 /PRNewswire/ -- Stiefel, a GSK (NYSE: GSK) company, today announced that the US Food and Drug Administration has approved the New Drug Application for Fabior (tazarotene) Foam, 0.1%. It is the only retinoid in a ...

FDA approves GSK topical acne treatment - SmartBrief

Want to see more news summaries? Sign up for AHIP Solutions SmartBrief AHIP Solutions SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news ...

FDA approves GSK's topical acne treatment Fabior - SmartBrief

GlaxoSmithKline received FDA approval to market Fabior, or tazarotene foam, a retinoid for those age 12 and older with acne vulgaris. The foam is contraindicated in pregnancy and might harm the fetus, the company said.

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK